• Share
  • Email
  • Print

Shilin Huang

Fax +886.2.2325.5838
Mr. Huang is a partner in K&L Gates’ Taipei office whose practice emphasizes dispute resolutions, including commercial litigation and international arbitrations. He has extensive cross-strait litigation experience, including leading patent and commercial disputes, both involving clients with interests in China and Taiwan. He is the member of Chartered Institute of Arbitrators (CIArb), the director of CIArb Taiwan Chapter (East Asia Branch) and the director of China Europe Arbitration Center (CEAC). He has been listed in the Panel of Arbitrators in China Arbitration Association since 2000.

Professional Background

Prior to joining K&L Gates, Mr. Huang was serving on the Copyright Committee when Taiwan adopted the modern international practises in reforming the Copyright Act. He then started his private practice by joining litigation firms and has worked with several multinational companies.

Professional/Civic Activities

  • Lecturer at Minghsin University of Science and Technology
  • Co-founder of Chartered Institute of Arbitrators (CIArb), Hong Kong Branch, Taiwan Chapter
  • Director of the Board of Chinese European Legal Association (Hamburg, Germany)

Speaking Engagements

  • “The Fun of Dispute Resolution”, Shanghai University of Political Science and Law, 2014 
  • “A Comparison of International and Domestic Arbitration Practice”, East China University of Political Science and Law, 2014
  • “Resolving Disputes Through International Arbitration under the IPA”, CIArb Taiwan Chapter (East Asia Branch), 2013
  • “Legal system in Taiwan”, National Taiwan University, 2013
  • “Introduction to International Arbitration”, National Taipei University, 2013
  • “Corporate Governance”, Minghsin University of Science and Technology, 2013
  • “Recent Development of Insider Trading in US”, CID Group, 2012
  • “Arbitration in Taiwan Region and Recent developments in Greater China Dispute Resolution”, Munich China Arbitration Day, 2012
  • “Insider Trading”, National Taipei University, 2009
  • “Cross-border Litigations”, Soochou University, 2008

Additional Information

  • “Factors Potentially Compromise the Independency of the Letter of Credit in Taiwan”, International Litigation News, September 2013
  • The Dispute Resolution Review, Taiwan Chapter, Fourth Edition, April 2012
  • “A Bridge Over Troubled Waters: Taiwan’s Legal Regime for Handling Investments from PRC Entities,” China Law & Practice, November 2005
  • “Security over Immovables in Selected Jurisdictions: Taiwan,” The Comparative Law Yearbook of International Business, Special Issue, 2005
  • Acting for the Taiwanese branch of a U.S. pharmaceutical company in relation to a US$10 million claim following the alleged wrongful termination of a distributorship agreement. The dispute subject to Taiwanese law relates to issues of jurisdiction of the tribunal to adjudicate disputes in respect of a contract terminated; the ability of a party to assert contractual rights of termination without knowledge of the existence of the contract and a wide ranging enquiry into the remoteness of damages claimed. The arbitration was held in Taiwan under ICC Rules.
  • Representing a Taiwan-based pharmaceutical company in defending an international arbitration case filed by its distributor with the Chamber of Commerce in Milan, Italy. The claim amounted to US$ 400 million. The arbitration is in Milan under the rules of Milan Chamber of Commerce. The applicable law is Italian law.
  • Representing a U.S. multi-level marketing company in Taiwan to file a commercial arbitration case arising from breach of confidentiality under a settlement agreement. The arbitration is in Taiwan under the rules of Chinese Arbitration Association. The applicable law is Taiwanese law.
  • Representing a government owned company on a claim for invalidation of arbitral award under CAA Rules in relation to a US$30 million claim on the ground of the tribunal was lack of mandate to render the award.
  • Representing management team in defending numerous litigations arising from a financial holding company attempted to hostile take over a government owned financial holding company.
  • Representing a public company with operations both in Taiwan and China, in defending a toxic torts case regarding a US$8 million claim in Taiwan. In this case, we successfully introduced epidemiology theory into the court system, which has never been used in Taiwan in deciding causation in torts cases.
  • Representing several commercial banks in defending litigations arising from structure notes issued by Lehman Brothers Group.